These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28842416)

  • 21. Dysfunction of Neuromuscular Synapses in the Genetic Model of Alzheimer's Disease.
    Mukhamedyarov MA; Grigor'ev PN; Ushanova EA; Zefirov TL; Leushina AV; Zefirov AL
    Bull Exp Biol Med; 2018 Sep; 165(5):669-673. PubMed ID: 30255242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors.
    Shemer I; Holmgren C; Min R; Fülöp L; Zilberter M; Sousa KM; Farkas T; Härtig W; Penke B; Burnashev N; Tanila H; Zilberter Y; Harkany T
    Eur J Neurosci; 2006 Apr; 23(8):2035-47. PubMed ID: 16630051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation of the Hippocampal POMC/MC4R Circuit Alleviates Synaptic Plasticity Impairment in an Alzheimer's Disease Model.
    Shen Y; Tian M; Zheng Y; Gong F; Fu AKY; Ip NY
    Cell Rep; 2016 Nov; 17(7):1819-1831. PubMed ID: 27829153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presenilins and APP in neuritic and synaptic plasticity: implications for the pathogenesis of Alzheimer's disease.
    Chan SL; Furukawa K; Mattson MP
    Neuromolecular Med; 2002; 2(2):167-96. PubMed ID: 12428810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
    Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
    Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synaptic Compensation as a Probable Cause of Prolonged Mild Cognitive Impairment in Alzheimer's Disease: Implications from a Transgenic Mouse Model of the Disease.
    Baazaoui N; Flory M; Iqbal K
    J Alzheimers Dis; 2017; 56(4):1385-1401. PubMed ID: 28222506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C-terminal fragment of N-cadherin accelerates synapse destabilization by amyloid-β.
    Andreyeva A; Nieweg K; Horstmann K; Klapper S; Müller-Schiffmann A; Korth C; Gottmann K
    Brain; 2012 Jul; 135(Pt 7):2140-54. PubMed ID: 22637581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of synaptic dysfunction in Alzheimer's disease.
    Masliah E
    Histol Histopathol; 1995 Apr; 10(2):509-19. PubMed ID: 7599445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gamma-protocadherins are targeted to subsets of synapses and intracellular organelles in neurons.
    Phillips GR; Tanaka H; Frank M; Elste A; Fidler L; Benson DL; Colman DR
    J Neurosci; 2003 Jun; 23(12):5096-104. PubMed ID: 12832533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
    Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
    J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tripchlorolide improves cognitive deficits by reducing amyloid β and upregulating synapse-related proteins in a transgenic model of Alzheimer's Disease.
    Zeng Y; Zhang J; Zhu Y; Zhang J; Shen H; Lu J; Pan X; Lin N; Dai X; Zhou M; Chen X
    J Neurochem; 2015 Apr; 133(1):38-52. PubMed ID: 25661995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early Presymptomatic Changes in the Proteome of Mitochondria-Associated Membrane in the APP/PS1 Mouse Model of Alzheimer's Disease.
    Völgyi K; Badics K; Sialana FJ; Gulyássy P; Udvari EB; Kis V; Drahos L; Lubec G; Kékesi KA; Juhász G
    Mol Neurobiol; 2018 Oct; 55(10):7839-7857. PubMed ID: 29468564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synaptic dysfunction in Alzheimer's disease.
    Marcello E; Epis R; Saraceno C; Di Luca M
    Adv Exp Med Biol; 2012; 970():573-601. PubMed ID: 22351073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice.
    Trinchese F; Liu S; Battaglia F; Walter S; Mathews PM; Arancio O
    Ann Neurol; 2004 Jun; 55(6):801-14. PubMed ID: 15174014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ErbB4 deficiency exacerbates olfactory dysfunction in an early-stage Alzheimer's disease mouse model.
    Deng XH; Liu XY; Wei YH; Wang K; Zhu JR; Zhong JJ; Zheng JY; Guo R; Zhu YF; Ye QH; Wang MD; Chen YJ; He JQ; Chen ZX; Huang SQ; Lv CS; Zheng GQ; Liu SF; Wen L
    Acta Pharmacol Sin; 2024 Dec; 45(12):2497-2512. PubMed ID: 38982150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hydrogen Sulfide Ameliorates Homocysteine-Induced Alzheimer's Disease-Like Pathology, Blood-Brain Barrier Disruption, and Synaptic Disorder.
    Kamat PK; Kyles P; Kalani A; Tyagi N
    Mol Neurobiol; 2016 May; 53(4):2451-2467. PubMed ID: 26019015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amyloid beta inhibits ectodomain shedding of N-cadherin via down-regulation of cell-surface NMDA receptor.
    Uemura K; Kuzuya A; Aoyagi N; Ando K; Shimozono Y; Ninomiya H; Shimohama S; Kinoshita A
    Neuroscience; 2007 Mar; 145(1):5-10. PubMed ID: 17257767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gender difference in valproic acid-induced neuroprotective effects on APP/PS1 double transgenic mice modeling Alzheimer's disease.
    Long Z; Zeng Q; Wang K; Sharma A; He G
    Acta Biochim Biophys Sin (Shanghai); 2016 Oct; 48(10):930-938. PubMed ID: 27614317
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks.
    Palop JJ; Mucke L
    Nat Neurosci; 2010 Jul; 13(7):812-8. PubMed ID: 20581818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cadherin-10 Maintains Excitatory/Inhibitory Ratio through Interactions with Synaptic Proteins.
    Smith KR; Jones KA; Kopeikina KJ; Burette AC; Copits BA; Yoon S; Forrest MP; Fawcett-Patel JM; Hanley JG; Weinberg RJ; Swanson GT; Penzes P
    J Neurosci; 2017 Nov; 37(46):11127-11139. PubMed ID: 29030434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.